Breaking News Instant updates and real-time market news.

MGLN

Magellan Health

$77.65

4.4 (6.01%)

20:38
07/13/17
07/13
20:38
07/13/17
20:38

Magellan Health upgraded to Overweight from Sector Weight at KeyBanc

  • 28

    Jul

MGLN Magellan Health
$77.65

4.4 (6.01%)

07/13/17
JEFF
07/13/17
NO CHANGE
Target $88
JEFF
Buy
Magellan acquisition should be 'meaningfully accretive,' says Jefferies
Jefferies analyst David Styblo believes Magellan Health paid a reasonable price for Senior Whole Health while the deal will allow it to expand into new markets. Senior Whole's financial profile is "strong" and should be "meaningfully accretive" to Magellan, Styblo tells investors in a research note. He keeps a Buy rating on the shares with an $88 price target.
01/23/17
LEER
01/23/17
NO CHANGE
Target $250
LEER
Outperform
Leerink sees Humana as target again after broken deal
After a judge sided with the Department of Justice in blocking Aetna's (AET) buyout of Humana (HUM), Leerink analyst Ana Gupte believes Humana could become a takeover target. Cigna (CI) is the most likely bidder, followed by Anthem (ANTM), Express Scripts (ESRX) and CVS Health (CVS), Gupte tells investors in a research note. The analyst expects Anthem's buyout of Cigna to also be blocked. After Humana, Gupte sees WellCare (WCG), Molina Healthcare (MOH) and Magellan Health (MGLN) as the most likely publicly traded targets post the deal breaks. She reiterates an Outperform rating on Humana with a standalone price target of $250. The stock is down 97c to $199.56 in afternoon trading.
12/23/16
JEFF
12/23/16
NO CHANGE
Target $89
JEFF
Buy
Jefferies expects Magellan to rally today on Virginia win
Jefferies analyst David Styblo expects shares of Magellan Health (MGLN) to rally today on the news that the company was one of seven managed care organizations selected for the $3.5B Virginia Managed Long Term Services and Supports initiative. Besides the financial benefit, the award shows Magellan can compete for business serving acute populations, Styblo tells investors in a research note titled "Santa Delivers Early for MGLN in Virginia." The other six winners include Aetna (AET), Anthem (ANTM), Humana (HUM), UnitedHealth (UNH), Optima Health and Virginia Premier, the analyst notes. Styblo reiterates a Buy rating on Magellan with an $89 price target.
09/26/16
JEFF
09/26/16
NO CHANGE
Target $76
JEFF
Buy
Magellan Health shares have 40% upside, says Jefferies
Jefferies analyst David Styblo views Magellan Health as "significantly undervalued" following the stock's 25% pullback since late July. The biggest investor concern centers on the steeper than usual earnings ramp in the second half of the year in order to achieve guidance, Styblo tells investors in a research note. He believes Magellan will achieve its guidance and sees 40% upside in the shares. The analyst lowered his price target for Magellan to $76 from $86 and keeps a Buy rating on the shares.

TODAY'S FREE FLY STORIES

AGN

Allergan

$189.27

2.12 (1.13%)

08:25
10/20/17
10/20
08:25
10/20/17
08:25
Recommendations
Allergan analyst commentary  »

Allergan price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 23

    Oct

  • 01

    Nov

  • 06

    Nov

08:25
10/20/17
10/20
08:25
10/20/17
08:25
General news
Fed funds futures are lower as safe haven flows unwind as risk appetite jumps »

Fed funds futures are…

WBC

Wabco

$155.08

6.01 (4.03%)

08:23
10/20/17
10/20
08:23
10/20/17
08:23
Recommendations
Wabco analyst commentary  »

Wabco price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$59.78

-8.21 (-12.08%)

08:22
10/20/17
10/20
08:22
10/20/17
08:22
Recommendations
United Continental analyst commentary  »

Limited visibility keeps…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENBL

Enable Midstream

$15.60

0.06 (0.39%)

08:22
10/20/17
10/20
08:22
10/20/17
08:22
Downgrade
Enable Midstream rating change  »

Enable Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

$DJT

DJ Transportation Average

08:22
10/20/17
10/20
08:22
10/20/17
08:22
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

08:21
10/20/17
10/20
08:21
10/20/17
08:21
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

08:21
10/20/17
10/20
08:21
10/20/17
08:21
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$177.87

-0.23 (-0.13%)

08:21
10/20/17
10/20
08:21
10/20/17
08:21
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$60.69

-0.18 (-0.30%)

08:20
10/20/17
10/20
08:20
10/20/17
08:20
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$67.64

-0.21 (-0.31%)

08:20
10/20/17
10/20
08:20
10/20/17
08:20
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

08:20
10/20/17
10/20
08:20
10/20/17
08:20
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:20
10/20/17
10/20
08:20
10/20/17
08:20
General news
Canada CPI preview »

Canada CPI preview:…

XLB

S&P Select Materials SPDR

$58.24

0.22 (0.38%)

08:19
10/20/17
10/20
08:19
10/20/17
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$54.82

0.57 (1.05%)

08:19
10/20/17
10/20
08:19
10/20/17
08:19
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$54.03

-0.29 (-0.53%)

08:19
10/20/17
10/20
08:19
10/20/17
08:19
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKX

Skechers

$24.03

-1.06 (-4.22%)

08:18
10/20/17
10/20
08:18
10/20/17
08:18
Recommendations
Skechers analyst commentary  »

Evercore ISI initiates a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$83.79

0.51 (0.61%)

08:18
10/20/17
10/20
08:18
10/20/17
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$149.29

-0.23 (-0.15%)

08:18
10/20/17
10/20
08:18
10/20/17
08:18
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QURE

uniQure

$15.16

5.69 (60.08%)

08:18
10/20/17
10/20
08:18
10/20/17
08:18
Technical Analysis
Technical View: uniQure hits fresh 52-week highs, levels to watch »

The stock is up over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$231.47

0.19 (0.08%)

08:18
10/20/17
10/20
08:18
10/20/17
08:18
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$255.79

0.07 (0.03%)

08:17
10/20/17
10/20
08:17
10/20/17
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$26.33

0.02 (0.08%)

08:17
10/20/17
10/20
08:17
10/20/17
08:17
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMH

Market Vectors Semiconductor

$97.85

-0.2 (-0.20%)

08:17
10/20/17
10/20
08:17
10/20/17
08:17
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QQQ

PowerShares QQQ Trust

$148.31

-0.55 (-0.37%)

08:16
10/20/17
10/20
08:16
10/20/17
08:16
Technical Analysis
PowerShares QQQ Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.